BLEX 404 plus gemcitabine for advanced pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This Phase 2 study tests whether adding BLEX 404 to gemcitabine can improve outcomes for people with inoperable or metastatic pancreatic cancer. It may help shrink the cancer or slow its growth by combining two treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 20 to 80 years old when you sign consent
- Have pancreatic adenocarcinoma that cannot be operated on or has spread (metastatic)
- Your health status should be mild to moderate (ECOG 1–2)
- Your blood counts, liver tests, and kidney function must be within safe limits
- You must have at least one spot of cancer that can be measured on scans
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, LM-302, combined with gemcitabine for people with a specific type of advanced pancreatic cancer that has not responded to or stopped working on first-line treatment. The goal is to see if the combination is safe and effective.
This trial studies a chemotherapy combination (albumin-bound paclitaxel and gemcitabine) as first treatment for pancreatic cancer that cannot be removed by surgery. It aims to improve outcomes by testing how well this treatment works in people with locally advanced or metastatic disease.
This study tests whether adding pitavastatin (a cholesterol-lowering drug) to gemcitabine chemotherapy can help treat pancreatic cancer that cannot be surgically removed. You would join if your cancer hasn't grown worse after 2–4 rounds of gemcitabine.
This trial tests AK104 (an antibody medicine) given with standard chemotherapy as the first treatment for advanced pancreatic ductal cancer. It aims to see whether this combination works better and is safe for people with cancer that has spread or is advanced.
This trial tests a combination of three medicines to see if they can slow down or shrink pancreatic cancer that has not responded to previous treatments or has come back. It might help if you are generally healthy and your cancer is advanced.
This Phase 1/2 study tests whether BLEX 404 taken by mouth, added to pemetrexed plus cisplatin chemotherapy, is safe and works better for certain people with newly diagnosed advanced lung cancer. It mainly looks for side effects first, and also checks tumor response.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.